RISE: Reporting and Intervention for Stars Excellence
Improve and Maintain Star Ratings
RISE is a comprehensive Star Ratings Improvement program that focuses on positive outcomes for Medicare Part D (Part D) clinical measures, including:
- Medication adherence for diabetes medications
- Medication adherence for hypertension (RAS antognists)
- Medication adherence for cholesterol (SUPD)
- Polypharmacy: Use of multiple anticholinergic medications in older adults (Poly-ACH)
- Concurrent use of opioids and benzodiazepines
Combined, these measures comprise a large proportion of the Part D Star Ratings calculation and heavily influence the largest weighted measure: Drug Plan Quality Improvement. When paired with our Medication Therapy Management (MTM) program, health plans have the opportunity to provide comprehensive clinical support to their members to improve outcomes, reduce cost and improve Star Ratings.
“It is our passion to improve Star Ratings through clinical interventions, and our privilege to walk with members on their unique health journeys.”
Amanda Lee, PharmD, Clinical Program Manager
Our Proprietary Application
RISE’s proprietary, web-based application performs three core functions: automated daily qualification, clinical intervention and on demand reporting. It is easy to use and its customizable settlings allow health plans to delegate interventions to the Navitus Clinical Engagement Center, complete interventions on their own using out software or use a hybrid access model.
The on-demand reporting feature includes near real-time data for unparallelled insight into plan goal progress. The analytics identify interventions to target members most in need of support. Our demonstrated results prove that interventions completed maximize Star Ratings impact.
Take the Next Step
Email us at [email protected] for more information about RISE or to set up a demonstration.
Stay Informed and Connected
Receive expert insights, healthcare tips, and important updates on pharmacy benefits, drug recalls, and more—straight to your inbox.
Examining Trends that Drive Informed Decisions
Now Available: 8th Annual Drug Trend Report
See the latest results and access industry insights you need to navigate current trend drivers.
Related blogs
Navigating Healthcare and Improving Outcomes
Associate Resource Group Spotlight: Green Team
The Green Team believes that small changes lead to significant impact. Whether its reducing waste, conserving energy or implementing eco-friendly initiatives, they serve as an internal hub for expertise regarding environmental sustainability….
PBM 101: The Three PBM Business Models
In the pharmaceutical and healthcare industry, pharmacy benefit managers (PBMs) are regarded by the media as intermediaries between drug manufacturers, pharmacies, health plans and plan sponsors. But they’re so much more than that. PBMs act as conduits…
An Automated Approach to Diagnosis Verification of GLP-1 RA for Type 2 Diabetes Mellitus (T2DM)
This study examines the impact of implementing an automated point-of-sale diagnosis verification system for glucagon-like peptide-1 receptor agonists (GLP-1 RAs) compared to traditional utilization management approaches….
Navitus to Remove Stelara® from Formulary July 1, 2025, Adds Biosimilars to Drive $120 Million in Savings
As the nation’s first 100% transparent, pass-through PBM, we continue to advance medication affordability by prioritizing upfront, real-time savings over rebated models….
Achieving Outstanding Results with Tailored Network Strategies
A medium-sized city in Michigan with 1,350 members was seeking ways to lower its pharmacy benefit costs, which were growing under its existing traditional pharmacy benefit manager (PBM). With its member covered by a two-tier, open formulary including…
Breaking Through Barriers with Value-Based Plan Design
Facing increased pharmacy benefit expenses, Blain’s Farm and Fleet, a Midwestern employer group, desired to improve plan performance. Specifically it was interested in educating eligible members about the benefits available to them, promoting cost-effective…
Finding a Solution to Lower Prescription Drug Costs
The Rural Arizona Group Health Trust (RAGHT) wanted to gain better control of its escalating drug trend with its large, traditional pharmacy benefit manager (PBM). Having only worked with traditional PBMs in the past, RAGHT was interested in exploring…
Empowered by Strategic Opportunities and Service Excellence
Putnam | Northern Westchester Health Benefits Consortium (PNW HBC) was the first municipal cooperative health plan in the state of New York to become certified by the Department of Insurance. They are dedicated to meeting — and exceeding — the standards…
QALYiQ Program Delivers Significant Savings for Both Members and Health Plans
As part of their treatment plan for hypophosphatasia (HPP), a rare genetic disorder affecting bone and teeth development, one of our members required Strensiq, a medication designed to manage HPP. However, Strensiq’s annual treatment costs ranged from…
